zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2023 / An U.S. patent titled “METHOD FOR PREPARING PLECTRANTHUS AMBOINICUS FRACTION HAVING ANTI-ARTHRITIS ACTIVITY” has been granted.

An U.S. patent titled “METHOD FOR PREPARING PLECTRANTHUS AMBOINICUS FRACTION HAVING ANTI-ARTHRITIS ACTIVITY” has been granted.

2023-01-17

Published Date:2023-01-17

Original Link:https://www.onenessbio.com/en/news_detail196_5.htm

No 2 Date of announcement 2023/01/17 Time of announcement 18:28:34
Subject An U.S. patent titled “METHOD FOR PREPARING PLECTRANTHUS AMBOINICUS FRACTION HAVING ANTI-ARTHRITIS ACTIVITY” has been granted.
To which item it meets paragraph 53 Date of events 2023/01/17
Statement
  1. Date of occurrence of the event:2023/01/17
  2. Company name:ONENESS BIOTECH CO., LTD.
  3. Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office
  4. Reciprocal shareholding ratios:NA
  5. Cause of occurrence:The Company has been informed by the patent agency that an U.S. patent titled ”METHOD FOR PREPARING PLECTRANTHUS AMBOINICUS FRACTION HAVING ANTI-ARTHRITIS ACTIVITY” has been granted under the patent number US 11,517,604 B2.
  6. Countermeasures:None
  7. Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):
    This patent is to protect one of the indications which the fraction of Plectranthus amboinicus has the potential to address. The Company will develop new indications for the fraction of Plectranthus amboinicus based on business requirements.